Tonix Pharmaceuticals adds second major managed Medicare agreement for TONMYA
Tonix announced a new pharmacy benefit manager agreement, effective immediately, that covers TONMYA for about 21 million Medicare Part D beneficiaries. The company says total commercial and government coverage for TONMYA now reaches about 166 million individuals, which expands the patients who can access the drug.
Key points
- New agreement adds about 21 million Medicare lives, or 38% of about 55 million Medicare lives in the U.S.
- Medicare coverage for TONMYA now totals 32 million lives, or 58% of Medicare lives in the U.S.
- Total commercial and government coverage reaches about 166 million covered lives, or 53% of about 314 million total U.S. lives
- Sales force totals 150 representatives after about 50 were fully activated
The filing
Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 22, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.